In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Smith & Nephew plc

http://www.smith-nephew.com

Latest From Smith & Nephew plc

Market Brief: Tissue-Engineered Wound Care Market Expected To Reach $1.9Bn By 2024 Amid Rising Chronic Disease

The skin replacement market is led by three key players who have all been impacted by COVID-19, but the sector may see a quicker rebound than others as treatments cannot be deferred for a long time.

Wound Management Wound Healing & Tissue Repair

Waters Muddied As Bharat Readies COVID-19 Vaccine For '21 Launch

As Bharat Biotech prepares its COVID-19 vaccine for a launch in the quarter ending next 30 September and claims at least 60% efficacy, questions arise over why trials were not temporarily halted following a serious adverse event during Phase I and why this wasn’t disclosed to participants in subsequent studies.

Coronavirus COVID-19 Vaccines

Zydus Cadila Opens New Fronts In COVID-19 Battle

With seven COVID-19 treatment/prophylactic candidates lined up, India's Zydus Cadila is unleashing all it can to combat the disease. Meanwhile, the firm has also offered an update on the state of its injectables and transdermals business in the US, which is contingent on resolving deficiencies at its Moraiya plant.

Coronavirus COVID-19 Strategy

Zydus Cadila Opens New Fronts In COVID-19 Battle

With seven COVID-19 treatment/prophylactic candidates lined up, India's Zydus Cadila is unleashing all it can to combat the disease. While Phase III data for its DNA vaccine candidate is expected by April, the latest to join the pack is ZYIL1, a novel oral small molecule NLRP3 inhibitor.

Commercial Coronavirus COVID-19
See All

Company Information

  • Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Other Names / Subsidiaries
    • Acufex Microsurgical, Inc.
    • ADERMA
    • ArthroCare Corporation
    • Atracsys Sàrl
    • Blue Belt Holdings, Inc.
    • Blue Belt Technologies
    • Ceterix Orthopaedics, Inc.
    • EuroCiencia Colombia
    • Healthpoint Biotherapeutics
    • Kalypto Medical
    • Leaf Healthcare, Inc.
    • LifeModeler
    • Nucryst Pharmaceuticals
    • Osiris Therapeutics, Inc.
    • Plus Orthopedics
    • Richards Medical Company
    • Rotation Medical, Inc.
    • Tenet
UsernamePublicRestriction

Register